000 01198 a2200313 4500
005 20250514234934.0
264 0 _c20050919
008 200509s 0 0 eng d
022 _a0315-162X
040 _aNLM
_beng
_cNLM
100 1 _aKotter, Ina
245 0 0 _aInterferon-a (IFN-a) application versus tumor necrosis factor-a antagonism for ocular Behçet's disease: focusing more on IFN.
_h[electronic resource]
260 _bThe Journal of rheumatology
_cAug 2005
300 _a1633; author reply 1634 p.
_bdigital
500 _aPublication Type: Comment; Comparative Study; Letter
650 0 4 _aAntibodies, Monoclonal
_xtherapeutic use
650 0 4 _aAntirheumatic Agents
_xtherapeutic use
650 0 4 _aBehcet Syndrome
_xcomplications
650 0 4 _aHumans
650 0 4 _aImmunologic Factors
_xtherapeutic use
650 0 4 _aInfliximab
650 0 4 _aInterferon-alpha
_xtherapeutic use
650 0 4 _aTumor Necrosis Factor-alpha
_xantagonists & inhibitors
650 0 4 _aUveitis
_xdrug therapy
700 1 _aDeuter, Cristoph
700 1 _aStubiger, Nicole
700 1 _aZierhut, Manfred
773 0 _tThe Journal of rheumatology
_gvol. 32
_gno. 8
_gp. 1633; author reply 1634
999 _c15717175
_d15717175